Product NDC: | 52584-050 |
Proprietary Name: | Cortrosyn |
Non Proprietary Name: | Cortrosyn |
Active Ingredient(s): | .25 mg/mL & nbsp; Cortrosyn |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-050 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016750 |
Marketing Category: | NDA |
Start Marketing Date: | 20100301 |
Package NDC: | 52584-050-00 |
Package Description: | 1 VIAL in 1 BAG (52584-050-00) > 1 mL in 1 VIAL |
NDC Code | 52584-050-00 |
Proprietary Name | Cortrosyn |
Package Description | 1 VIAL in 1 BAG (52584-050-00) > 1 mL in 1 VIAL |
Product NDC | 52584-050 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cortrosyn |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Start Marketing Date | 20100301 |
Marketing Category Name | NDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | COSYNTROPIN |
Strength Number | .25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC] |